Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Dividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Repurchased
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Non-cash Items (2012 - 2025)

Pharma-Bio Serv posted quarterly Non-cash Items of $406680.0 for Q4 2025, up 25.76% year-on-year from $323370.0 in Q4 2024, and up 25.76% on a QoQ basis from $323370.0 in Q4 2024.

Pharma-Bio Serv (PBSV) has 13 years of Non-cash Items data on file, last reported at $406680.0 in Q4 2025.

  • For the quarter ending Q4 2025, Non-cash Items rose 25.76% year-over-year to $406680.0; the trailing twelve-month figure through Oct 2025 stood at $406680.0 (up 25.76% YoY), and the FY2025 full-year result was $406680.0, up 4762.27% from the prior year.
  • Non-cash Items for Q4 2025 stood at $406680.0, up from $323370.0 in the prior quarter.
  • Across five years, Non-cash Items topped out at $406680.0 in Q4 2025 and bottomed at $14800.0 in Q4 2022.
  • The 5-year median for Non-cash Items is $263330.0 (2023), against an average of $216456.0.
  • The widest annual swing landed in 2022, when Non-cash Items slumped 80.03%; it then soared 1679.26% in 2023.
  • A 5-year view of Non-cash Items shows it stood at $74100.0 in 2021, then plunged by 80.03% to $14800.0 in 2022, then jumped by 1679.26% to $263330.0 in 2023, then rose by 22.8% to $323370.0 in 2024, then increased by 25.76% to $406680.0 in 2025.
  • The last three Non-cash Items figures came in at $406680.0 (Q4 2025), $323370.0 (Q4 2024), and $263330.0 (Q4 2023), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn
10 Pharma-Bio Serv - - 722,374.00

Historic Data

Download Data 🔒
DateValue
Oct 31, 2025 406,680.00
Oct 31, 2025 406,680.00
Oct 31, 2024 323,370.00
Oct 31, 2024 323,370.00
Oct 31, 2023 263,330.00
Oct 31, 2023 263,330.00
Oct 31, 2022 14,800.00
Oct 31, 2022 14,800.00
Oct 31, 2021 74,100.00
Oct 31, 2021 74,100.00
Oct 31, 2020 202,700.00
Oct 31, 2020 202,700.00
Oct 31, 2019 270,000.00
Oct 31, 2019 270,000.00
Oct 31, 2018 190,000.00
Oct 31, 2018 190,000.00
Oct 31, 2017 74,570.00
Oct 31, 2017 74,570.00
Oct 31, 2016 147,000.00
Oct 31, 2016 147,000.00
Oct 31, 2015 165,000.00
Oct 31, 2015 165,000.00
Oct 31, 2013 523,327.00
Oct 31, 2013 523,327.00
Oct 31, 2012 180,000.00
Oct 31, 2012 180,000.00